Press Releases

MEMPHIS, Tenn., Jan. 21, 2020 /PRNewswire/ -- Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed the acquisition of Cobra Biologics, a leading CDMO specialized in providing development and manufacturing services for plasmid DNA and vira

WOODCLIFF LAKE, N.J., Jan. 21, 2020 /PRNewswire/ -- Eisai announced today the presentation of three abstracts at the 2020 Gastrointestinal Cancers Symposium (#GI20) in San Francisco from January 23-25. New data to be presented on lenvatinib

WALTHAM, Mass., Jan. 21, 2020 /PRNewswire/ -- MicroMedicine™, a life sciences technology company and the leader in high throughput microfluidic cell selection, washing, and concentration, is excited to announce the initial steps of a collaboration with HemaCare® (A Charles River Company), the global leader in human-derived biological products

BEDFORD, N.H., Jan. 21, 2020 /PRNewswire/ -- Ferrotec (USA) Corporation, the US subsidiary of Ferrotec Holdings Corp., a global supplier of materials, components, and precision system solutions and the leading manufacturer of magnetic liquids, today announced the PBG-series of polyethylene glycol (PEG) based ferrofluids for bio-medic

MESA, Ariz., Jan. 21, 2020 /PRNewswire/ -- The Marchand Institute for Minimally Invasive Surgery released a warning today regarding new lines of small a

WASHINGTON, Jan. 21, 2020 /PRNewswire/ -- Washington, DC-based healthcare technology startup Socially Determined announced today that it has closed its Series A investment round

CHICAGO, Jan. 21, 2020 /PRNewswire/ -- Vyaire Medical, Inc. today announced that its Board of Directors has appointed Gaurav Agarwal as Chief Executive Officer, effective immediately. Agarwal succeeds Dave Eckley, who is stepping down as Chief Executive Officer, but will remain on the company's Board of D

RADNOR, Pa., Jan. 21, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE:  AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory

CAMBRIDGE, Mass., Jan. 21, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it has commenced an underwritten public offering of $325,000,000 in shares of its common stock. In addition, Blue

NORTHBROOK, Ill., Jan. 21, 2020 /PRNewswire/ -- For the sixth consecutive year, Astellas has achieved a perfect score on the Human Rights Campai